|
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 140 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Breast Cancer clinical trial scenario. This report .....
Introduction GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Metastatic Breast Cancer 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Metastatic Breast Cancer 25 Subjects Recruited Over a Period of Time 33 Prominent Sponsors 34 Top Companies Participating in Metastatic Breast Cancer Therapeutics Clinical Trials 36 Prominent Drug Comparison 38 Clinical Trial Profiles 39 Clinical Trial Overview of Top Companies 39 GlaxoSmithKline plc 39 Clinical Trial Overview of GlaxoSmithKline plc 39 Eli Lilly and Company 42 Clinical Trial Overview of Eli Lilly and Company 42 F. Hoffmann-La Roche Ltd. 44 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44 Novartis AG 47 Clinical Trial Overview of Novartis AG 47 Bristol-Myers Squibb Company 49 Clinical Trial Overview of Bristol-Myers Squibb Company 49 Pfizer Inc. 51 Clinical Trial Overview of Pfizer Inc. 51 AstraZeneca PLC 53 Clinical Trial Overview of AstraZeneca PLC 53 Amgen Inc. 55 Clinical Trial Overview of Amgen Inc. 55 Celgene Corporation 56 Clinical Trial Overview of Celgene Corporation 56 Sanofi 57 Clinical Trial Overview of Sanofi 57 Genentech, Inc. 58 Clinical Trial Overview of Genentech, Inc. 58 Taiho Pharmaceutical Co., Ltd. 59 Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 59 Intas Pharmaceuticals Ltd. 60 Clinical Trial Overview of Intas Pharmaceuticals Ltd. 60 Eisai Inc. 61 Clinical Trial Overview of Eisai Inc. 61 Boehringer Ingelheim GmbH 62 Clinical Trial Overview of Boehringer Ingelheim GmbH 62 US Oncology, Inc. 63 Clinical Trial Overview of US Oncology, Inc. 63 ARCAGY - GINECO 64 Clinical Trial Overview of ARCAGY - GINECO 64 Merck & Co., Inc. 65 Clinical Trial Overview of Merck & Co., Inc. 65 Johnson & Johnson 66 Clinical Trial Overview of Johnson & Johnson 66 Dr. Reddy's Laboratories Limited 67 Clinical Trial Overview of Dr. Reddy's Laboratories Limited 67 Clinical Trial Overview of Top Universities / Institutes / Hospitals 68 The University of Texas M. D. Anderson Cancer Center 68 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 68 Memorial Sloan Kettering Cancer Center 72 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 72 Dana-Farber Cancer Institute 74 Clinical Trial Overview of Dana-Farber Cancer Institute 74 Vanderbilt-Ingram Cancer Center 75 Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 75 Sarah Cannon Research Institute 76 Clinical Trial Overview of Sarah Cannon Research Institute 76 University of Medicine and Dentistry New Jersey 77 Clinical Trial Overview of University of Medicine and Dentistry New Jersey 77 FUDAN University 78 Clinical Trial Overview of FUDAN University 78 Fred Hutchinson Cancer Research Center 79 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 79 Southeastern Medical Oncology Center 80 Clinical Trial Overview of Southeastern Medical Oncology Center 80 Stanford University 81 Clinical Trial Overview of Stanford University 81 Sidney Kimmel Comprehensive Cancer Center 82 Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 82 Northwestern University 83 Clinical Trial Overview of Northwestern University 83 Mayo Clinic 84 Clinical Trial Overview of Mayo Clinic 84 European Organization for Research and Treatment of Cancer 85 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 85 Southwest Oncology Group 86 Clinical Trial Overview of Southwest Oncology Group 86 Duke University 87 Clinical Trial Overview of Duke University 87 Washington University School of Medicine 88 Clinical Trial Overview of Washington University School of Medicine 88 Albert Einstein College of Medicine of Yeshiva University 89 Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 89 University of Michigan Comprehensive Cancer Center 90 Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 90 New York University School of Medicine 91 Clinical Trial Overview of New York University School of Medicine 91 Five Key Clinical Profiles 92 Appendix 137 Abbreviations 137 Definitions 137 Research Methodology 138 Secondary Research 138 About GlobalData 139 Contact Us 139 Disclaimer 139 Source 140 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15 Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 18 Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 20 Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Metastatic Breast Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 Metastatic Breast Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26 Metastatic Breast Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 33 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 35 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 37 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 38 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 39 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 42 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 44 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 47 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 49 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 51 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 53 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 55 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 56 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 57 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 58 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 59 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Intas Pharmaceuticals Ltd., 2012* 60 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 61 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 62 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by US Oncology, Inc., 2012* 63 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCAGY - GINECO, 2012* 64 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 65 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 66 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2012* 67 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 68 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 72 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 74 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012* 75 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 76 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 77 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 78 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 79 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012* 80 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 81 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 82 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 83 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 84 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 85 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 86 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 87 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012* 88 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2012* 89 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 90 Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012* 91 List of Figures Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15 Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 33 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 34 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 36 Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 38 GlobalData Methodology 138 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
